Prosecution Insights
Last updated: October 25, 2026

Hoffmann & Baron LLP

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

94 pending office actions • 72 clients • 90 examiners • 67 art units • 0 of 94 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Hoffmann and Baron, LLP has 1 pending office action in Medical Devices & Mechanical Engineering. Its career history includes 10362 applications, providing extensive filing context for the single active matter shown.

The resolved allowance rate is 80.15%, and allowed matters have required an average of 3.32 office actions. The figures support separate evaluation of historical results and examination effort, rather than treating the current pending count as a measure of overall prosecution performance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=10362 apps, methodology: how we score firms)

80.2%
Allowance Rate
n=10362
+0.64σ
Allowance Rate (norm)
n=10362
3.3
OAs to Allowance
n=6407
-0.21σ
OAs to Allow (norm)
n=6407
1109 days
Time to Allowance
n=6407
+8.1pp
Interview Lift
n=10362
23.3%
RCE Rate
n=10362
1.2%
Appeal Rate
n=10362

Rejection Performance (% of received rejections ultimately overcome)

82.8%
§101 Overcome
n=606
79.1%
§102 Overcome
n=2556
79.7%
§103 Overcome
n=3965
82.0%
§112 Overcome
n=3494

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
17%
Top-3 CPC Share
n=10362
4
Practitioners
n=10362
2590.5
Apps / Practitioner
n=10362

Portfolio Summary

94
Total Pending OAs
64
Non-Final OAs
28
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 31 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

16
Overdue
2
Due this week
8
Due this month
1
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 31 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (16)Due ≤ 7 days (2)Due ≤ 30 days (8)Due ≤ 60 days (1)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

56
Hard (60%)
27
Medium (29%)
10
Easy (11%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 + other9 (10%)
§103 only20 (21%)
§102 only1 (1%)
§112 only9 (10%)
Double-patenting only1 (1%)
Double-patenting + other6 (6%)
Multi-statute (no §101)47 (50%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

66
Life Sciences
70% of docket
2
Information Tech
2% of docket
2
Communications
2% of docket
1
Semiconductors
1% of docket
21
Mechanical / Eng
22% of docket
2
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

940 h
Manual time on pending OAs
188 h
Time saved (low, 20%)
329 h
Time saved (mid, 35%)
8.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOBSON, STEPHEN 2 65.0% +20.1%
AEDER, SEAN E 2 56.9% +20.0%
GOLDBERG, JEANINE ANNE 2 45.4% +40.5%
BRISTOL, LYNN ANNE 2 63.4% +39.8%
MACFARLANE, EVAN H 1 50.7% +42.3%
MELCHIOR, JAMES RYLAND 1 62.2% +39.5%
REYES, REGINALD R 1 40.9% +31.5%
HODGE, LINDA J 1 87.7% +26.6%
JACKSON, MONIQUE R 1 34.8% +44.3%
NG, JONATHAN K 1 35.6% +14.2%

Hard Cases (56)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18378432 Anorectal Rectal Junction Device RABAGLIA, BRIDGET ELIZABETH 88d overdue
17502238 Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof BRISTOL, LYNN ANNE 66d overdue
18950653 COMMUNICATION ALERT SYSTEM FOR UNAUTHORIZED POOL ENTRY RUSHING, MARK S 53d overdue
18808671 System for Mounting Photovoltaic Modules for an Overhead Structure CANNON, RYAN SMITH 18d overdue
18005813 T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof QIAN, CELINE X 18d overdue
17691107 DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES KIM, DANIELLE A 5d overdue
18273197 METHOD AND SYSTEM FOR FORMING TUBULAR OR TRUNCATED CONICAL SEGMENTS TOLAN, EDWARD THOMAS 2d overdue
18284348 SYSTEM HAVING A GUIDE RAIL AND A CARRYING DEVICE DO, NHAT CHIEU Q 5d

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17502238 Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof BRISTOL, LYNN ANNE 66d overdue
17921543 TREATMENT OF HER2 NEGATIVE, MAMMAPRINT HIGH RISK 2 BREAST CANCER AEDER, SEAN E 36d overdue
17994787 CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS THEREOF BRISTOL, LYNN ANNE 70d
19236083 SUCTION DEVICE AND HANDHELD POWER SAW MACHINE EQUIPPED THEREWITH MACFARLANE, EVAN H —
19195720 ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents MELCHIOR, JAMES RYLAND —
19191089 SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES REYES, REGINALD R —
19111233 TRANSFER DEVICE FOR TRANSFERRING AN ARRAY OF DOSES OF MEDICINES HODGE, LINDA J —
19105886 THERMOCHROMIC MATERIALS WITH NANOPARTICLES JACKSON, MONIQUE R —

Client Portfolio (72 clients)

View all 72 →

Top Art Units

Art UnitApps
16133
16423
16823
16833
37242
16442
17872
16262
16152
36432

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19236083 SUCTION DEVICE AND HANDHELD POWER SAW MACHINE EQUIPPED THEREWITH Festool GmbH MACFARLANE, EVAN H 3724 §103§112 Non-Final OA — Pending Jun 12, 2025
19195720 ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents Crosslink Therapeutics Inc. MELCHIOR, JAMES RYLAND 1644 §112DP Final Rejection — Pending Apr 30, 2025
19191089 SYSTEM AND METHOD FOR MAKING PERSONALIZED INDIVIDUAL UNIT DOSES CONTAINING PHARMACEUTICAL ACTIVES Aquestive Therapeutics, Inc. REYES, REGINALD R 3684 DP Non-Final OA — Pending Apr 28, 2025
19111233 TRANSFER DEVICE FOR TRANSFERRING AN ARRAY OF DOSES OF MEDICINES Global Factories Total Engineering And Manufacturing B.V. HODGE, LINDA J 3731 §102§103 Non-Final OA — Pending Mar 12, 2025
19105886 THERMOCHROMIC MATERIALS WITH NANOPARTICLES Chemelot Scientific Participations B.V. JACKSON, MONIQUE R 1787 §102§103§112 Non-Final OA — Pending Feb 24, 2025
19027751 NETWORK-ENABLED GLOBAL POSITIONING SATELLITE-BASED DEVICE FOR OBTAINING PATIENT VERIFICATION Rearden Analytics NG, JONATHAN K 3619 §101§103Other Non-Final OA — Pending Jan 17, 2025
18996380 A CUBICLE AND A STABLE R. Andringa Holding B.V. TRUONG, KATELYN T 3647 §102§103§112 Non-Final OA — Pending Jan 17, 2025
18877527 Method, System, and Non-Transitory Computer-Readable Recording Medium for Providing Messenger Service Hopae Inc. GILLESPIE, KAMRYN JORDAN 2408 §102 Non-Final OA — Pending Dec 20, 2024
18724493 Method, System, and Non-Transitory Computer-Readable Recording Medium for Supporting Asset Transaction Korea Securities Lending Co., Ltd. POE, KEVIN T 3692 §101§103§112 Non-Final OA 23d Pending Dec 16, 2024
18975116 DECORATIVE FOIL, METHOD FOR PRODUCING A DECORATIVE FOIL AND METHOD FOR DECORATING A TARGET SUBSTRATE Leonhard Kurz Stiftung & Co. Kg KOCH, GEORGE R 1745 §102§103§112 Non-Final OA — Pending Dec 10, 2024
18871556 PRODUCING 2,5-FURANDICARBOXYLIC ACID FROM MIXED FEED Furanix Technologies B.V. HAVLIN, ROBERT H 1626 §103§112DP Non-Final OA — Pending Dec 04, 2024
18950653 COMMUNICATION ALERT SYSTEM FOR UNAUTHORIZED POOL ENTRY Acqua Angel, LLC RUSHING, MARK S 2689 §102§103 Final Rejection 53d overdue Pending Nov 18, 2024
18948847 TRANSFER FILM, COMPONENT, AND METHOD FOR THE PRODUCTION THEREOF Leonhard Kurz Stiftung & Co. Kg LIANG, SHIBIN 1741 §103§112 Non-Final OA — Pending Nov 15, 2024
18865801 RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION Mana Health Technologies GmbH PALENIK, JEFFREY T 1615 §103 Non-Final OA — Pending Nov 14, 2024
18931317 PROCESS FOR FORMING IMPROVED PROTECTIVE ECO-FRIENDLY POUCH AND PACKAGING AND PRODUCTS MADE THEREFROM Graphic Innovators, LLC HELVEY, PETER N. 3736 §102§103 Non-Final OA — Pending Oct 30, 2024
18930407 SECUREMENT APPARATUS FOR A PORTABLE ELECTRONIC DEVICE Daca Design LLC WAGGENSPACK, ADAM J 3734 §103§112Other Non-Final OA — Pending Oct 29, 2024
18858989 AIR CONDITIONING SYSTEM AND AIR CONDITIONING METHOD Shimizu Corporation BANKS, KEONA LAUREN 3763 §103 Final Rejection — Pending Oct 22, 2024
18854771 PLANT PLUG, MANUFACTURING METHOD AND USE THEREOF Klasmann-Deilmann GmbH ALMEIDA BONNIN, ANGELICA ALEJANDRA 3643 §103§112 Non-Final OA — Pending Oct 07, 2024
18854537 HYDROTHERMAL TREATMENT OF MATERIALS Mura Technology Limited CEPLUCH, ALYSSA L 1772 §102§103§112 Non-Final OA — Pending Oct 06, 2024
18904685 TOFACITINIB CITRATE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF Oryza Pharmaceuticals Shenzhen Limited MILLER, MAKENNA RYLEIGH §103§112 Non-Final OA — Pending Oct 02, 2024
18891727 Method for Nitrogen Removal and Nitrogen Salts Recovery Using Carboxylated Cellulose Extracted by Nitro-oxidation The Research Foundation for the State University of New York GURTOWSKI, RICHARD C 1773 §103 Non-Final OA — Pending Sep 20, 2024
18849392 LIQUID FORMULATIONS OF IVERMECTIN COMPOSITIONS AND USE IN GELATIN DOSAGE FORMS Catalent Pharma Solutions, LLC CHI, AMANDA LYNN 1613 §103§112 Non-Final OA — Pending Sep 20, 2024
18826507 WATERPROOF BIODEGRADABLE COIR POT WITH NATURAL SPECIAL WATERPROOF COATING Toyo Cushion Lanka (PVT) LTD BYUN, HAE RIE JESSICA 3643 §103 Final Rejection 87d overdue Pending Sep 06, 2024
18844132 MARINE STRUCTURE AND METHOD Daewoo Engineering & Construction Co., Ltd. VENNE, DANIEL V 3615 §102§103 Non-Final OA — Pending Sep 05, 2024
18808671 System for Mounting Photovoltaic Modules for an Overhead Structure Lumos Solar, Inc. CANNON, RYAN SMITH 1726 §102§103 Final Rejection 18d overdue Pending Aug 19, 2024
18837631 HEIGHT ADJUSTABLE VENTILATION SYSTEM Beektech Industries B.V. DALLO, JOSEPH J 3747 §102§103§112 Non-Final OA — Pending Aug 12, 2024
18836880 APPARATUS AND METHOD FOR GRINDING SEEDS La San Marco S.p.A. DICKSTEIN, WILLIAM DOUGLAS 3725 §102§103§112 Non-Final OA — Pending Aug 08, 2024
18727441 RETICULAR PANEL FOR A COOLING TOWER Spig S.p.A. HOBSON, STEPHEN 1776 §102§103§112 Non-Final OA — Pending Jul 09, 2024
18727446 THERMAL EXCHANGE PACK FOR A COOLING TOWER Spig S.p.A. HOBSON, STEPHEN 1776 §103§112 Non-Final OA — Pending Jul 09, 2024
18740403 Methods and vectors for in vitro transcription of mRNA with reduced levels of dsRNA Applied DNA Sciences, Inc. ZAHORIK, AMANDA MARY 1636 §103§112 Non-Final OA — Pending Jun 11, 2024
18735752 EFFICIENT CHATTER CUTTING METHOD FOR DIFFICULT-TO-MACHINE MATERIALS BEIHANG UNIVERSITY SNYDER, ALAN W 3722 §102§103 Final Rejection — Pending Jun 06, 2024
18716599 MULTI-APPLICATION MODULE, MULTI-APPLICATION DEVICE, AND WORKING METHOD FOR A MULTI-APPLICATION DEVICE Leonhard Kurz Stiftung & Co. Kg THOMPSON, LESLIE J. 2853 §103§112 Non-Final OA — Pending Jun 05, 2024
18714631 NOVEL NON-FLUORINATED QUINOLONE COMPOUND AND USE THEREOF Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory OTTON, ALICIA L 1699 §112 Non-Final OA — Pending May 30, 2024
18663847 METHOD FOR THE TREATMENT OF PATIENTS WITH CARCINOMAS Centro De Inmunologia Molecular LU, CHENG 1642 §103§112Other Non-Final OA — Pending May 14, 2024
18658193 ORGANIC COMPOUND AND ELECTROLUMINESCENT DEVICE Sichuan Ag-Ray New Materials Co., Ltd. RHOADES, DEREK JAMES 1692 §102§103 Non-Final OA — Pending May 08, 2024
18703558 METHODS FOR GENETIC ANALYSIS OF TEXTILES COMPRISING G. BARBADENSE Applied DNA Sciences, Inc. BAUSCH, SARAE L 1699 §101§103 Non-Final OA — Pending Apr 22, 2024
18700394 METHOD FOR DETECTING INSULATOR FAULT OF TRANSMISSION LINE BASED ON USRNet AND IMPROVED MobileNet-SSD ALGORITHM Chongqing University VAZ, JANICE EZVI 2667 §103 Final Rejection 47d Pending Apr 11, 2024
18629619 CONSTRUCTION METHOD OF BACTERIAL CELLULOSE (BC)-ENRICHED PLANT USING MULTI-GENE TANDEM AND USE THEREOF Shanghai Academy Of Agricultural Sciences DELEO, VICTORIA LYNN 1662 §103§112 Non-Final OA — Pending Apr 08, 2024
18695655 CRYSTALLIZATION METHOD AND CRYSTALLIZATION APPARATUS Tsukishima Kikai Co., Ltd. PEREZ, JELITZA M 1774 §103 Non-Final OA — Pending Mar 26, 2024
18694118 Methods of Inhibiting Diseases Caused by Respiratory Viruses Biomedit, LLC ZEMAN, ROBERT A 1645 §103§112Other Non-Final OA — Pending Mar 21, 2024
18694065 METHODS FOR PRESERVING HEALTHY INTESTINAL MICROBIOME DURING GROWTH PROMOTER ADMINISTRATION Biomedit, LLC DAUNER, JOSEPH G 1682 §101§102§103 Final Rejection — Pending Mar 21, 2024
18689624 METHODS FOR TREATING NEUROGENERATIVE DISEASES Ptc Therapeutics, Inc. WILSON, JERICA KATLYNN 1621 §103 Final Rejection — Pending Mar 06, 2024
18425001 SELF-CLOSING DISPENSING VALVE MADE OF A PLASTOMER OR A THERMOPLASTIC ELASTOMER Weener Plastics Group B.V. ZADEH, BOB 3754 §102§103 Non-Final OA 14d Pending Jan 29, 2024
18425986 Reproducible Double Unique Dual Indexing Library Construction Method for Next Generation Sequencing of microRNA Isoform and Use Thereof Jiansheng Medical Technology Co., Ltd. HOPPE, EMMA RUTH 1683 §101§102§112 Non-Final OA — Pending Jan 29, 2024
18425696 COCKPIT WITH VIRTUAL CONTROL ELEMENTS DEUTSCHES ZENTRUM FÜR LUFT- UND RAUMFAHRT E.V. BIANCAMANO, ALYSSA N 3715 §103§112 Final Rejection — Pending Jan 29, 2024
18411101 COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF ICELL GENE THERAPEUTICS INC. REDDIG, PETER J 1646 §102DP Non-Final OA — Pending Jan 12, 2024
18410519 SYSTEM AND METHOD FOR MANAGING RELATIONSHIPS, ORGANIZATION, RETRIEVAL, AND SHARING OF DIFFERENT TYPES OF CONTENTS ACCESSIBLE BY A COMPUTING DEVICE Sgs Ventures Inc. OSMAN, RAMY M 2457 §103§112 Final Rejection — Pending Jan 11, 2024
18575677 PHYSIOLOGICALLY ACCEPTABLE YEAST COMPOSITIONS FOR USE IN THE TREATMENT OF A GASTRO-INTESTINAL DISORDER AB Mauri (Uk) Ltd. FIEBIG, RUSSELL G 1655 §103§112 Non-Final OA — Pending Dec 29, 2023
18575113 POLYCRYSTALLINE SIC FORMED BODY AND METHOD FOR PRODUCING THE SAME Tokai Carbon Co., Ltd. SONG, MATTHEW J 1714 §102§103 Final Rejection 14d Pending Dec 28, 2023
18564360 AMYLOPECTIN STARCH FOR BINDING OF MEAT PRODUCTS Coöperatie Koninklijke Avebe U.A. BEKKER, KELLY JO 1792 §103§112 Non-Final OA — Pending Nov 27, 2023

View all 94 →

Managing Hoffmann & Baron LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Hoffmann & Baron LLP's patent allowance rate?

80.2% of resolved applications prosecuted by Hoffmann & Baron LLP were allowed, across 10,362 applications in USPTO records.

How many office actions does Hoffmann & Baron LLP average before allowance?

3.32 office actions per allowed application on average.

How many pending office actions does Hoffmann & Baron LLP have?

94 pending office actions as of October 2026, for 72 clients, before 90 examiners in 67 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month